Literature DB >> 23426355

Mutations in the rotavirus spike protein VP4 reduce trypsin sensitivity but not viral spread.

Shane D Trask1, J Denise Wetzel2, Terence S Dermody3, John T Patton1.   

Abstract

Infectious entry of the nonenveloped rotavirus virion requires proteolysis of the spike protein VP4 to mediate conformational changes associated with membrane penetration. We sequenced and characterized an isolate that was cultured in the absence of trypsin and found that it is more resistant to proteolysis than WT virus. A substitution mutation abrogates one of the defined trypsin-cleavage sites, suggesting that blocking proteolysis at this site reduces the overall kinetics of proteolysis. Kinetic analysis of the membrane penetration-associated conformational change indicated that the 'fold-back' of the mutant spike protein is slower than that of WT. Despite these apparent biochemical defects, the mutant virus replicates in an identical manner to the WT virus. These findings enhance an understanding of VP4 functions and establish new strategies to interrogate rotavirus cell entry.

Mesh:

Substances:

Year:  2013        PMID: 23426355      PMCID: PMC3709623          DOI: 10.1099/vir.0.050674-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Structural rearrangements in the membrane penetration protein of a non-enveloped virus.

Authors:  Philip R Dormitzer; Emma B Nason; B V V Prasad; Stephen C Harrison
Journal:  Nature       Date:  2004-08-26       Impact factor: 49.962

2.  Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry.

Authors:  Irene S Kim; Shane D Trask; Marina Babyonyshev; Philip R Dormitzer; Stephen C Harrison
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

3.  Atomic model of an infectious rotavirus particle.

Authors:  Ethan C Settembre; James Z Chen; Philip R Dormitzer; Nikolaus Grigorieff; Stephen C Harrison
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

4.  VP5* rearranges when rotavirus uncoats.

Authors:  Joshua D Yoder; Shane D Trask; T Phuoc Vo; Mawuena Binka; Ningguo Feng; Stephen C Harrison; Harry B Greenberg; Philip R Dormitzer
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 5.  Structural insights into the coupling of virion assembly and rotavirus replication.

Authors:  Shane D Trask; Sarah M McDonald; John T Patton
Journal:  Nat Rev Microbiol       Date:  2012-01-23       Impact factor: 60.633

6.  Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.

Authors:  M K Estes; D Y Graham; B B Mason
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes.

Authors:  Marie Wolf; Phuoc T Vo; Harry B Greenberg
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

8.  Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without.

Authors:  J M Gilbert; H B Greenberg
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  Culturing, storage, and quantification of rotaviruses.

Authors:  Michelle Arnold; John T Patton; Sarah M McDonald
Journal:  Curr Protoc Microbiol       Date:  2009-11
View more
  2 in total

1.  Group A Rotavirus Associated with Encephalitis in Red Fox.

Authors:  Chiara Busi; Vito Martella; Alice Papetti; Cristiano Sabelli; Davide Lelli; G Loris Alborali; Lucia Gibelli; Daniela Gelmetti; Antonio Lavazza; Paolo Cordioli; M Beatrice Boniotti
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

Review 2.  Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.

Authors:  Tirth Uprety; Dan Wang; Feng Li
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.